First Nebraska Trust Co Makes New $5.25 Million Investment in Colgate-Palmolive Company $CL

First Nebraska Trust Co bought a new stake in Colgate-Palmolive Company (NYSE:CL) during the third quarter, HoldingsChannel.com reports. The institutional investor bought 61,567 shares of the company’s stock, valued at approximately $5,252,000.

A number of other large investors have also modified their holdings of the business. Corient Private Wealth LP increased its holdings in Colgate-Palmolive by 29.0% during the 2nd quarter. Corient Private Wealth LP now owns 639,604 shares of the company’s stock valued at $58,639,000 after acquiring an additional 143,812 shares in the last quarter. Bank of America Corp DE acquired a new stake in shares of Colgate-Palmolive during the second quarter worth $567,483,000. Brandywine Financial Group increased its stake in Colgate-Palmolive by 35,612.3% in the first quarter. Brandywine Financial Group now owns 72,853 shares of the company’s stock valued at $6,209,000 after purchasing an additional 72,649 shares during the last quarter. SEB Asset Management AB purchased a new position in Colgate-Palmolive during the first quarter worth about $91,149,000. Finally, Robinhood Asset Management LLC purchased a new position in Colgate-Palmolive during the second quarter worth about $11,554,000. 80.41% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

CL has been the topic of a number of research analyst reports. JPMorgan Chase & Co. decreased their price target on Colgate-Palmolive from $104.00 to $102.00 and set an “overweight” rating on the stock in a research note on Monday. Bank of America upped their price objective on shares of Colgate-Palmolive from $100.00 to $105.00 and gave the company a “buy” rating in a research note on Monday. Wells Fargo & Company increased their price objective on shares of Colgate-Palmolive from $90.00 to $95.00 and gave the stock an “equal weight” rating in a report on Monday. Piper Sandler decreased their target price on shares of Colgate-Palmolive from $98.00 to $95.00 and set an “overweight” rating on the stock in a research report on Monday, September 21st. Finally, Weiss Ratings downgraded shares of Colgate-Palmolive from a “buy (b-)” rating to a “hold (c+)” rating in a report on Friday, October 2nd. Thirteen analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $101.22.

Insider Activity

In other Colgate-Palmolive news, Director John Cahill sold 4,170 shares of the business’s stock in a transaction dated Thursday, August 6th. The stock was sold at an average price of $93.37, for a total transaction of $389,352.90. Following the transaction, the director owned 28,373 shares in the company, valued at $2,649,187.01. The trade was a 12.81% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, COO Panagiotis Tsourapas sold 10,000 shares of the business’s stock in a transaction dated Monday, August 24th. The stock was sold at an average price of $92.05, for a total value of $920,500.00. Following the transaction, the chief operating officer owned 64,901 shares in the company, valued at approximately $5,974,137.05. This represents a 13.35% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Company insiders own 0.43% of the company’s stock.

Colgate-Palmolive News Roundup

Here are the key news stories impacting Colgate-Palmolive this week:

• Positive Sentiment: Colgate-Palmolive beat third-quarter estimates, with sales up 4.6% year over year, and raised its EPS outlook while narrowing its 2026 sales outlook. Management cited resilient global demand and premium innovation, although costs remain a pressure. Q3 deep dive
• Positive Sentiment: Several analysts raised their targets after the results. Morgan Stanley lifted its target to $111 and kept an overweight rating; BNP Paribas Exane raised its target to $108 and reaffirmed outperform; RBC raised its target to $105 and maintained outperform. Analyst forecasts after Q3 earnings
• Neutral Sentiment: JPMorgan trimmed its target to $102 but retained an overweight rating. Barclays and Wells Fargo raised their targets to $95 while keeping equal-weight ratings, signaling limited upside at those firms’ estimates.
• Negative Sentiment: A valuation comparison noted that Colgate-Palmolive trades at a higher forward price-to-earnings multiple than Lululemon, raising questions about whether CL’s premium valuation is justified. Valuation comparison

Colgate-Palmolive Price Performance

Colgate-Palmolive stock opened at $95.36 on Wednesday. Colgate-Palmolive Company has a 52-week low of $75.00 and a 52-week high of $99.33. The firm has a fifty day moving average of $89.73 and a 200-day moving average of $89.77. The firm has a market capitalization of $75.80 billion, a P/E ratio of 25.11, a PEG ratio of 4.55 and a beta of 0.31. The company has a quick ratio of 0.30, a current ratio of 0.96 and a debt-to-equity ratio of 11.23.

Colgate-Palmolive (NYSE:CL) last issued its earnings results on Friday, October 30th. The company reported $0.97 EPS for the quarter, beating analysts’ consensus estimates of $0.93 by $0.04. The business had revenue of $5.37 billion for the quarter, compared to the consensus estimate of $5.34 billion. Colgate-Palmolive had a net margin of 9.65% and a return on equity of 607.88%. The business’s revenue for the quarter was up 4.6% compared to the same quarter last year. During the same quarter last year, the firm posted $0.91 EPS. As a group, analysts predict that Colgate-Palmolive Company will post 3.91 EPS for the current year.

Colgate-Palmolive Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, November 13th. Investors of record on Tuesday, October 20th will be issued a $0.53 dividend. This represents a $2.12 annualized dividend and a yield of 2.2%. The ex-dividend date is Tuesday, October 20th. Colgate-Palmolive’s dividend payout ratio is currently 83.14%.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company (NYSE: CL) is a global consumer products company focused on oral care, personal care, home care and pet nutrition. Its portfolio includes toothpaste, toothbrushes, mouthwash, liquid hand soap, body wash, deodorants, household cleaning products and pet food and treats.

The company markets well-known brands such as Colgate, Palmolive, elmex, meridol, Softsoap, Irish Spring, Ajax, Protex and Hill’s Science Diet. Colgate-Palmolive also provides veterinary and nutritional products through Hill’s Pet Nutrition, which serves pet owners and animal health professionals.

Founded in 1806 by William Colgate, the company developed from a soap and candle business into a diversified consumer goods manufacturer.